ENT & Allergy Practices Attract Private Equity
Focus Investment Banking
JULY 19, 2023
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. ENT and allergy is relatively new to private equity investment, with approximately ten major platforms currently operating. Yet only 7.1%
52 
Let's personalize your content